日本薬理学会年会要旨集
Online ISSN : 2435-4953
第94回日本薬理学会年会
セッションID: 94_2-O-D3-5
会議情報

一般演題(口頭)
脂肪由来幹細胞濾液を用いた間質性膀胱炎の新たな治療法の開発
*柴山 真純堀田 祐志前田 琴美松本 成史片岡 智哉山本 徳則木村 和哲
著者情報
キーワード: urinary bladder
会議録・要旨集 オープンアクセス

詳細
抄録

Hypothesis Interstitial cystitis (IC) is a chronic inflammatorydisease characterized by pain in the bladder and voiding symptoms. To date,there are no effective treatments for IC. We investigated whether filteredadipose-derived stem cell lysate (FADSCL) alleviates IC in a rat model ofHCl-induced cystitis.

Materials and methods Rat adipose-derived stem cells were collectedfrom the subcutaneous fat of rats, and FADSCL (lysate of 1×107 cells/PBS) wasprepared. Female Fisher 344 rats, aged eight weeks, were divided into thesham+PBS (sham, n=10), HCl+PBS (HCl, n=12), and HCl+FADSCL (FADSCL, n=9) groups.Saline or 0.1 M HCl (250μl/body) was intravesically administered from atransurethral catheter. Bladder function was investigated after one week bycystometrography. A sample of bladder tissue was used for RNA-seq analysis.

Results The intercontraction intervals (ICIs) in the HCl group weresignificantly shorter than those in the sham group (P<0.01), while the ICIsof the FADSCL group were significantly longer than those of the HCl group(P<0.01). There was no significant difference between the groups with respectto the maximum voiding pressure and bladder weight. RNA-Seq analysis revealed anincrease in immune and inflammatory signaling in the HCl group compared to thatin the sham group, and these signals were suppressed in the FADSCL group.

Conclusion FADSCL might alleviate IC via anti-inflammatory actionsand suppress the immune response. Thus, FADSCL could serve as a noveltherapeutic agent for IC.

著者関連情報
© 2021 本論文著者
前の記事 次の記事
feedback
Top